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Influenza viruses are one of the leading causes of morbidity and mortality during winter months. Increased respiratory rate (tachypnea) is
a sign of increasing lower respiratory disease during influenza infection and is frequently observed in hospitalized patients. We investigated
this clinical sign in influenza virus-infected cotton rats (Sigmodon hispidus) and the efficacy of antiviral and anti-inflammatory therapy in
reducing symptomatic disease. Cotton rats infected intranasally with A/Wuhan/359/95 (H3N2) had increased respiratory rates from 1 to
4 days postinfection that correlated with the dose of virus used to inoculate the animal but not the amount of virus recovered from the lung.
In addition, evaluation of sequential lung tissue pathology revealed that extensive epithelial cell destruction of small airways correlated with
tachypnea. Increased respiratory rate was not observed in immune animals, supporting results that demonstrated a requirement for exposure
to, and infection by, large amounts of live virus for induction of tachypnea. A variety of therapeutic approaches proved ineffective in
reducing tachypnea, including anti-inflammatory therapy with systemic triamcinolone acetonide, bronchodilatory therapy with levalbuterol,
or antiviral therapy with zanamivir. These results, together with the pathologic observations, suggest that early disruption of the lower
respiratory tract epithelium is a major component of the pathophysiology of influenza infection. Therapeutic approaches need to be tailored
to clear airway obstruction and restore an intact epithelium.
D 2004 Elsevier Inc. All rights reserved.Keywords: Tachypnea; Influenza; Cotton ratsIntroduction
Influenza virus causes numerous excess deaths each
winter (Thompson et al., 2003). Within 24 h of infection,
symptoms such as high fever, muscle ache, and lethargy are
experienced in most patients (Cate, 1987). Shortness of
breath that accompanies other clinical signs of influenza
has been used to distinguish patients with pneumonia from
those with an upper respiratory tract infection only (Oliveira
et al., 2001). Increased frequency of breath (tachypnea) is
also frequently seen in the elderly with pneumonia, although
typical symptoms of influenza infection are not always
evident (Musgrave and Verghese, 1990). Identification of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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may lead to a clearer understanding of viral pathology and
may point to strategies to treat influenza-infected patients
that have shortness of breath.
Changes in O2 and CO2 concentrations or receptor-
mediated signaling regulate respiration through the respira-
tory center in the medulla. These changes may come about
through mechanical alterations that limit airflow through
obstruction or constriction of the airways. Tachypnea could
be a result of airflow that is obstructed by increased amounts
of debris or mucus in the airways or by constriction of
smooth muscle around airways in response to increased
parasympathetic signals. Many inflammatory mediators as
well as the inflammatory cells themselves could contribute
to airway constriction (Ashraf et al., 2001; Miura et al.,
1989) through edema, tissue destruction, and increased
muscle tone. Tachypnea has been observed in squirrel
monkeys experimentally infected with influenza A/New
Table 1
Respiratory rate and virus titers in lungs and noses of cotton rats 2 days
after intranasal infection with influenza viruses
Animals infected
with
Geometric mean virus titer
(TCID50/ml)
a
Breaths/min FSD
(P)
Lungs Noses
No virus <102.3 <101.3 278 F 22
A/Wuhan/95 (H3N2) 103.2 106.6 496 F 24
(P < 0.0001)b
X-31 (H3N2) 104.6 106.2 451 F 27
(P < 0.0001)
A/PR/8/34 (H1N1)c 106.3 105.0 503 F 41
(P < 0.0001)
B/HK/73 103.6 105.8 334 F 12
(P = 0.03)
a Geometric mean titers are shown for four animals. Similar results have
been obtained in repeat experiments.
b Student’s t test was used to calculate the significance of differences
between the respiratory rate before (uninfected) and after infection with
each influenza virus.
c The A/PR/8/34 used in this experiment was a ‘‘tissue culture-adapted’’
strain obtained from ATCC.
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onset, transient change in airway function is thought to be a
result of epithelial cell damage although other mechanisms
have not been ruled out. Animal models that allow easy
monitoring of airway function and virus replication can be
used to determine the pathophysiologic mechanisms that
result in tachypnea.
Several human respiratory viruses replicate efficiently in
cotton rats (Sigmodon hispidus) and produce disease similar
to that described in humans. These include parainfluenza
viruses (Murphy et al., 1981; Ottolini et al., 1996; Porter et
al., 1991), respiratory syncytial virus (Prince et al., 1978),
adenovirus (Pacini et al., 1984), measles virus (Wyde et al.,
1992), and influenza virus (Ottolini et al., 2003). Cotton rats
therefore provide an alternative small animal model that can
be used to define mechanisms of pathogenesis that are likely
to correlate with human disease. In this report, we demon-
strate tachypnea in cotton rats that are infected with A/
Wuhan/359/95 (A/Wuhan/95) and show that this clinical
sign is dependent on the presence of replicating virus.
Although tachypnea correlates with both epithelial cell
destruction and inflammation, it is not resolved by treatment
with anti-inflammatory agents, supporting the idea that
destruction of the epithelium and airway obstruction may
mediate this clinical sign.Results
Cotton rats infected with many different influenza viruses
have increased respiratory rates
We infected groups of cotton rats with influenza viruses
A/Wuhan/95, X-31, A/PR/8/34 (tissue culture-adapted), and
B/HK/73. None of these viruses were adapted to growth in
cotton rats. Respiratory rates were measured daily and the
lungs and noses of some animals in each group homoge-
nized for virus titration. Virus was present in both the nose
and lung 2 days postinfection (p.i.) at which time the
respiratory rate of each infected animal was significantly
greater than that of uninfected animals (Table 1). Virus titers
obtained on day 2 p.i. are not the result of residual inoculum
because other studies in our laboratory that follow the
kinetics of replication show an eclipse phase at 4–8 h when
no virus is recovered from infected lungs followed by the
appearance of virus progeny (Ottolini et al., manuscript in
preparation). Virus is cleared from the lung by day 4 and
from the nose between days 7 and 10 for each virus strain
(results not shown). In contrast to these strains, replication
of mouse-adapted A/PR/8/34 in the cotton rat lower respi-
ratory tract is impaired: virus was not detected in lung
homogenates of cotton rats infected with this virus 2 days
previously, although the geometric mean titer in the nose
was 104.7 TCID50/ml.
The characteristics of virus-induced tachypnea were
further explored using A/Wuhan/95. Cotton rats were eitherleft untreated or infected intranasally with107 TCID50 A/
Wuhan/95 and airway measurements recorded at 24-h inter-
vals. Increased respiratory rate was evident in A/Wuhan/95
infected cotton rats on days 1, 2, and 3 p.i., with peak
measurements on day 2 p.i., and was resolved between days
4 and 7 p.i. (Fig. 1). Although the number of breaths per
minute was increased, the total volume of air that was
exchanged each minute (minute ventilation) remained sim-
ilar (results not shown) reflecting rapid but shallow breaths
after infection.
Tachypnea requires virus replication
Respiratory rates were measured in cotton rats infected
with live 107 TCID50 A/Wuhan/95 or with the same amount
of UV-light or heat-inactivated virus. Airway measurements
from four animals per group were compared to airway
measurements of four uninfected animals. Tachypnea was
evident only when animals were exposed to live virus (Fig.
2). In addition, enhanced pause (Penh), a measurement that
correlates with bronchoconstriction, was increased in cotton
rats infected with live but not inactivated virus. This
demonstrates that the altered respiratory rate and increased
Penh require replication and are not related to nonreplicating
components within the virus preparation. Similarly, ‘mock’
preparations of allantoic fluid or MDCK tissue culture
supernatants that do not contain virus did not induce
tachypnea (results not shown).
Tachypnea is dependent on the inoculation dose of
A/Wuhan/95 and not the resultant virus titer in the lung
On day 4 p.i. when the respiratory rate was close to
resolution, high titers of virus (>104 TCID50/ml) were still
present in the noses but no virus was isolated from the lungs
Fig. 3. The percentage of increase in respiratory rate is proportional to dose
of input virus. Groups of cotton rats were infected with dilutions of A/
Wuhan/95 containing 0.25 to 4  106 TCID50 particles. Daily airway
measurements were made and the percentage of increase in average
frequency of breath ( f ) calculated. Results are shown for day 1 p.i. The
standard deviation of each average was less than 10%. Respiratory rates in
animals infected with 4  106 and 2  106 TCID50 were significantly
different from that before infection (P < 0.0001). Differences in
respiratory rates after infection with 1  106 TCID50 or less were not
significant (P > 0.1).
Fig. 1. Respiratory rates of cotton rats infected with A/Wuhan/95. The
arithmetic mean frequency of breath (breaths/min) in cotton rats that were
not infected or infected with 1  107 TCID50 A/Wuhan/95 are shown
before infection (day 0) and 1, 2, 3, 4, and 7 days p.i. Four animals were
used in each group. Repeat experiments showed similar results. Tachypnea
was evident as significant increases in respiration rate on days 1, 2, and 3
(P < 0.01). The difference in frequency of breath of uninfected and
infected cotton rats was not always significant on day 4 p.i.
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virus replication in the lower and not upper respiratory tract
is related to the induction of tachypnea. However, the
increase in respiratory rate was proportional to the inocula-
tion dose (Fig. 3), with very little or no tachypnea evidentFig. 2. Tachypnea correlates with the presence of live virus. The percentage
of difference between respiratory rate of cotton rats that were not
inoculated and cotton rats inoculated with live (solid bar), heat-treated
(grey bar), or UV-treated (stippled bar) A/Wuhan/95 is shown. The
percentage of difference between Penh for each of these groups is also
depicted. Measurements from four animals/group were compared to airway
measurements of four uninfected animals and are shown for day 3 post-
inoculation with 107 TCID50 (or an equivalent number of inactive virus
particles). Repeat experiments with respiratory rate measured 2 days post-
inoculation gave similar results. Respiratory rates between uninfected
animals and animals infected with live A/Wuhan/95 were significantly
different (P < 0.0002). Inoculation of animals with virus that was either
heat or UV-treated did not result in significant differences in respiratory
rates (P = 0.9 and 0.2, respectively).after infection with less than 1  106 TCID50 A/Wuhan/95,
although virus replication is vigorous at this dose and less.
For example, no tachypnea is induced in animals infected
with 2  104 TCID50 A/Wuhan/95, although the geometic
mean virus titers in the lungs and noses were 105.5 and 106.1
TCID50/ml, respectively, similar to those obtained when a
greater inoculum is used. Tachypnea therefore correlates
with the amount of infectious virus that is used to inoculate
the animal intranasally and not the amount of virus that
replicates in the lung. This suggests that this clinical sign is
a consequence of very early rounds of A/Wuhan/95 repli-
cation in the lower respiratory tract.
Tachypnea correlates with epithelial cell damage and
inflammatory cell recruitment
To determine whether tachypnea correlates with changes
in histology, cotton rats were infected with either 107 or 2 
104 TCID50 A/Wuhan/95, and lungs harvested at 24-h inter-
vals after infection. Each of these doses resulted in vigorous
viral replication in lungs and noses, but significant increases
in the respiratory rates of infected animals compared to
uninfected animals were only observed after infection with
107 TCID50 A/Wuhan/95 (similar to that shown in Fig. 1).
H/E-stained slides were examined for epithelial cell destruc-
tion (absence of an intact epithelial layer that results in
exposure of the basement membrane and presence of
grossly abnormal epithelial cells that have distended cyto-
plasms or are pycnotic) and the accumulation of inflamma-
tory cells or cellular debris in the lumen of the airways.
Recruitment of inflammatory cells around bronchioles (peri-
bronchiolitis), or within the alveoli (alveolitis) and alveoli
Fig. 4. Extensive pathology is evident in lungs of tachypneic cotton rats.
Arithmetic mean histopathology score for (A) epithelial destruction and (B)
peribronchiolitis in lungs of cotton rats 1, 2, 3, 4, and 5 days p.i. with either
107 (grey bars) or 2  104 (black bars) TCID50 A/Wuhan/95. The average
score for six animals/group is shown. An * denotes differences in
histopathology score that were statistically significant (P < 0.05) between
animals infected with 107 and animals infected with 2  104 TCID50
A/Wuhan/95.
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these parameters was scored from 0 to 4 (0 being represen-
tative of no histopathology and 4 being representative ofFig. 5. Percentage of increase in respiratory rate 2 days after infectionwith influenza
are shown for four to seven animals that were infected with 107 A/Wuhan/95 w
zanamivir, steroid and zanamivir, or levalbuterol. A group of immune animals that ha
A/Wuhan/95. No virus replication was observed in either the lungs or noses of immextensive histopathology). Fig. 4 shows the arithmetic mean
pathology score for epithelium destruction (A) and peri-
bronchiolitis (B) in the small airways of cotton rats infected
with either 107 or 2  104 TCID50 A/Wuhan/95. Despite the
recovery of similar virus titers in the lungs and noses of
these two groups of animals, the difference in both the
destruction of the epithelium and inflammatory response
between these two groups of animals was obvious: both
were more severe in lungs of animals infected with the
higher dose of virus with very little disruption of the
epithelium or inflammation in cotton rats infected with the
lesser dose. Similar differences in scores for accumulation
of cells in the airway lumen (scores similar to that of
epithelium damage), interstitial pneumonitis, and alveolitis
were also recorded (results not shown). Both destruction of
epithelium and inflammation were maximum 2 days p.i. and
approached that of normal tissue 5 days after infection. The
average scores for destruction of large airway epithelium
were similar to that of the small airway.
Tachypnea is not diminished by treatment with a
bronchodilator or antiviral or anti-inflammatory agents,
but is prevented in immune animals
To determine whether tachypnea can be resolved by
treatment with an antiviral agent, cotton rats were infected
with A/Wuhan/95 and treated with zanamivir, an inhibitor of
neuraminidase activity, at 24 and 48 h p.i. Plethysmography
showed that the tachypnea 2 days after infection was not
diminished with this treatment (Fig. 5). Airway measure-
ments made on days 1, 2, 3, and 7 p.i. demonstrated that the
duration of tachypnea in zanamivir-treated animals was
similar to untreated infected animals, with complete resolu-
tion by day 7 p.i. At day 2 p.i., the pathology evident in H/
E-stained lung sections from animals that had been treated
with zanamivir was moderately reduced compared to un-
treated infected animals but still showed abnormal small andvirus and treatment with therapeutic agents. Themean percentage of increases
ithout further treatment, or treated with steroid (triamcinolone acetamide),
d been previously been exposed to A/Wuhan/95was also challenged with 107
une cotton rats. The SD of respiratory rate within each group was <10%.
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as well as extensive peribronchiolitis (Fig. 6).
To identify the contribution of inflammatory cells to
tachypnea, A/Wuhan/95-infected cotton rats were treated
with a glucocorticoid, triamcinolone acetonide, at a dose 
 
  
 
Fig. 6. Photomicrograph at 64 magnification of H/E-stained sections of
formalin-fixed lungs from cotton rats that were either (A) uninfected, (B)
infected 2 days previously with 107 TCID50 A/Wuhan/95 without further
treatment, (C) infected 2 days previously and treated with zanamivir at 24
h p.i., or (D) infected 2 days previously and treated with triamcinolone at 24
h p.i. Arrows point to pycnotic cells (closed arrowheads), sloughing cell
(double shafted arrows), and resultant denuded areas (open arrowheads).that has been used to reduce inflammation after influenza
virus infection in cotton rats (Ottolini et al., 2003). In the
triamcinolone-treated group, the percentage of increase in
respiratory rate on days 1, 2, and 3 p.i. was similar to A/
Wuhan/95-infected cotton rats that had not been treated with
the drug (Fig. 5), with resolution by day 7 p.i. (results not
shown). Inflammation observed on H/E-stained lung sec-
tions was reduced by treatment with triamcinolone. Damage
to airway epithelium was also reduced but clearly still
present in triamcinolone-treated cotton rats (Fig. 6).
To determine whether smooth muscle contraction and
consequent constriction of small and large airways contrib-
uted to virus-induced tachypnea, we treated A/Wuhan/95-
infected cotton rats with levalbuterol, a commonly used
bronchodilator that activates h2-adrenergic receptors on
smooth muscle cells to relax the airways. Animals were
exposed to levalbuterol as an aerosol at a dose that effec-
tively relieves bronchoconstriction in asthmatics. This dose
effectively reduced the increased Penh values (that reflect
bronchoconstriction) observed in cotton rats exposed to an
aerosol containing 30 mg/ml methacholine. This treatment
did not reduce tachypnea in A/Wuhan/95-infected cotton
rats (Fig. 5).
The increased respiratory rate was prevented in animals
that had been infected with A/Wuhan/95 4 weeks before
challenge (Fig. 5). No virus was isolated from the lungs or
nose of these animals at day 2 p.i. confirming that replica-
tion is required to induce tachypnea.Discussion
Cotton rats can be infected with many influenza virus
strains without adaptation to this host, providing a model
system to explore viral pathogenesis. In this study, we
demonstrated increased respiratory rates in cotton rats that
were infected with several influenza viruses. The character-
istics of influenza-induced tachypnea and potential preven-
tion or treatment strategies were addressed.
Tachypnea was evident early after infection and resolved
soon after virus was cleared from the lower respiratory tract
(but not the nose), suggesting that this was a direct effect of
virus on lung function or early inflammatory events, rather
than a result of immune mediators secreted by antigen-
specific cells of the adaptive immune response that are
recruited to the lung at later time points. Initial experiments
used 107 TCID50 A/Wuhan/95 to characterize this disease
sign. When animals were infected with doses less than 106
TCID50, they did not become tachypneic, although equiva-
lent titers of virus were recovered from the lungs, suggesting
that the dose of input virus, not the dose of progeny virus,
results in the induction of tachypnea. Because we also
demonstrated that live virus is required to induce tachypnea,
these results suggest that tachypnea is the result of events
dictated by early rounds of replication of influenza in the
lower respiratory tract.
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important strategies to reduce the mortality and morbidity
associated with annual epidemics as well as potential influ-
enza pandemics. Immunization with influenza virus vaccine
is most effective in healthy young adults. Although vacci-
nation is less effective in the elderly, it does reduce hospi-
talization and death due to influenza infection in this
population. Our results demonstrate that prior exposure to
the same strain of influenza protects from virus replication
and virus-induced tachypnea. This supports our results that
show induction of tachypnea requires virus replication.
Examination of pathology in lungs after influenza virus
infection showed that tachypnea correlated with epithelial
cell destruction, the resultant accumulation of cellular debris
in the airway lumen, as well as peribronchiolitis. To deter-
mine whether inflammatory cells that infiltrate the lung
resulted in airway constriction and consequently contributed
to the increased respiratory rate, we used triamcinolone
acetamide to decrease the extent of inflammation in the
lungs of A/Wuhan/95-infected cotton rats. Peribronchiolitis,
but not tachypnea, was dramatically reduced. It is therefore
unlikely that any mechanical changes brought about by the
presence of inflammatory cells or products of these early
inflammatory cells contribute to influenza virus-induced
tachypnea. The increased respiratory rate that is unresolved
by this treatment is likely to result from destruction of the
airway epithelium that is still evident.
Although zanamivir is clearly an effective means of
limiting influenza virus spread and reducing disease (Hay-
den et al., 1997; von Itzstein et al., 1993), we show that this
drug is not effective at treating influenza virus-induced
tachypnea in cotton rats. Because our results suggest that
early rounds of replication are likely to result in tachypnea
in this animal model, it is not surprising that this NA
inhibitor had little effect on either epithelial cell destruction
or tachypnea when administered 24 h p.i. Furthermore,
treatment with zanamivir worsened the tachypnea. This
effect was abrogated by combining treatment with zanami-
vir with steroid, suggesting that zanamivir either has a direct
or indirect (perhaps by inhibition of viral neuraminidase
activity) adverse effect on recruited inflammatory cells.
Alternatively, because extravasation of neutrophils is de-
pendent on endogenous sialidase activity (Cross et al.,
2003), the use of a NA inhibitor may reduce the recruitment
of these cells that could possibly alleviate tachypnea by
secretion of specific cytokines or other soluble factors.
Combination therapy in this case may alleviate the zanami-
vir-dependent increase by reducing the presence of other
inflammatory cells that may be producing factors that result
in bronchoconstriction. Although inflammatory cells may
contribute to zanamivir-directed increase in respiratory rate,
they are unlikely to play a role in the induction of influenza-
induced tachypnea.
In these studies, we have not examined the effectiveness
of other influenza antivirals in the treatment or prevention of
tachypnea. Like zanamivir, oseltamivir inhibits neuramini-dase activity and therefore is unlikely to reduce the first
round of virus infection and consequent increased respira-
tory rate. However, because this drug is administered orally,
a mode of delivery that would overcome possible hindran-
ces by airway obstruction, the outcome may be different and
warrants testing. We predict that very early administration of
amantadine or rimantidine may effectively reduce tachypnea
because these drugs block virus entry. However, like neur-
aminidase inhibitors, this class of drug is unlikely to reduce
already established tachypnea that results from very early
rounds of replication.
Because a large number of epithelial cells are destroyed
during influenza infection, factors secreted by these cells
would also not be present. Some of these may be ‘protective’
and contribute to the maintenance of healthy lung function.
This may be the case for prostaglandin E2 (PGE2) that is
produced by lung epithelial cells (Churchill et al., 1989) and
is known to protect against bronchoconstriction (Pavord and
Tattersfield, 1995). However, the in vivo contribution of the
epithelium as a source of PGE2 to maintain respiratory rate
may not be important because airway muscle cells also
produce significant amount of this prostaglandin (Asano et
al., 1996). A second example of a ‘‘protective’’ epithelial
cell factor is neutral endopeptidase, an enzyme that degrades
substance P, a tachykinin responsible for neurogenic inflam-
mation and bronchoconstriction. Although smooth muscle
cell reactivity to substance P is increased in vitro during
influenza virus infection due to decreased activity of neutral
endopeptidase (Jacoby et al., 1988), our experiments that
use levalbuterol to reduce smooth muscle constriction were
not successful in reducing influenza virus-induced tachyp-
nea. This supports the idea that constriction of the airways
does not mediate influenza virus-induced tachypnea. In-
stead, injury of the epithelium and resultant obstruction of
airways by cellular debris is more likely to play a primary
role in this manifestation of respiratory disease.
It is likely that the tissue destruction that is evident after
infection with 107 but not 2  104 TCID50 influenza virus is
a result of an increased proportion of simultaneously
infected epithelial cells. The lack of epithelial pathology
after infection of cotton rats with the lower doses of A/
Wuhan/95 is clearly not due to a lack of virus replication but
may reflect efficient replacement of cells that are infected
sequentially rather than at the same time. An understanding
of the mechanisms that facilitate the differentiation and
replacement of epithelial cells may result in the identifica-
tion of ways to restore a healthy epithelium in cases where it
has been obliterated. In addition, effective treatments for
influenza virus-induced tachypnea are likely to include
those that prevent the destruction of the respiratory epithe-
lium or that facilitate the clearance of airway obstruction.
It is important to design treatment strategies for lower
respiratory tract disease caused by influenza because large
number of individuals, including infants too young to be
vaccinated and the elderly, due to immunosenescence, are
not immune to the circulating strains of influenza virus. In
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and shift antigenically is that even a healthy vaccinated
population could succumb to infection by a newly emerging
strain. Further studies to identify specific mechanisms that
contribute to the induction and resolution of tachypnea will
facilitate the design of such therapeutic agents.Materials and methods
Cotton rats
Male and female inbred S. hispidus were obtained from a
breeding colony maintained at Virion Systems Inc., Rock-
ville, MD. Animals were seronegative for adventitious
viruses. Animals were used at 6–12 weeks of age in
protocols that follow federal regulations and were approved
by the institutional Animal Care and Use Committee.
Immune animals were generated by intranasal exposure to
2  106 TCID50 A/Wuhan/95 at least 3 weeks before
inoculation with the challenge dose of virus.
Virus infection and titrations
A large pool of A/Wuhan/95(H3N2) was grown in
MDCK cells at Dyncorp (Rockville, MD) resulting in a
108 TCID50/ml stock virus. Similar titers of virus were
contained in stocks of X-31, B/HK/73, and mouse-adapted
A/PR/8/34 that were grown in 10-day-old embryonated
chicken eggs. Tissue culture-adapted A/PR/8/34 was
obtained from ATCC as a stock preparation grown in eggs
and then grown in a monolayer of MDCK cells. None of the
viruses were passaged in cotton rat cells or adapted to
replicate more efficiently in cotton rats by in vivo passage.
Virus was stored at 70 jC and thawed immediately before
use. Aliquots of virus were inactivated with UV light or heat
(1 h at 60 jC). Animals were anesthetized in 3% isoflurane
and then inoculated intranasally with 0.1 ml virus prepara-
tion containing the amount of virus indicated in the text.
Lungs and noses were surgically removed from animals that
were sacrificed by CO2 asphyxiation and homogenized in 3
ml DMEM supplemented with 0.218 M sucrose–4.9 mM
glutamate–3.8 mM KH2PO4–7.2 mM K2HPO4. The cellu-
lar debris was pelleted and supernate stored at 70 jC.
Influenza virus titers were determined for lungs and noses
on monolayers of MDCK cells as previously reported (Oh et
al., 2000). The titer was recorded as the inverse dilution that
resulted in cytopathic effect in 50% of infected wells
(TCID50) and is reported per 1 ml of homogenate. The
lowest level of virus detectable was 102.3 and 101.3 TCID50/
ml in lung and nasal homogenates, respectively.
Airway measurements
Unrestrained whole body plethysmography (Buxco Elec-
tronics Inc., Troy, NY) was used to measured frequency ofbreath ( f ). After calibration of the two-chamber equipment
(designed to hold adult rats) with 3 ml of air, one cotton rat
was placed in each plethysmograph chamber and airway
measurements made over a period of 5 min. In addition to f,
other parameters of airway function, including enhanced
pause (Penh), a calculated measure of airway responsive-
ness that reflects the ratio of inspiration and expiration rates
and the time between breaths, were recorded. Arithmetic
means of each airway parameter were calculated and are
presented in the figures.
Treatment of animals with potential therapeutic agents
Twenty-four hours postinfection, animals were anesthe-
tized as previously described and groups of at least four
animals either left untreated or treated with 4 mg/kg
triamcinolone acetonide (Kenolog-40; Bristol-Myers Squibb
Company, Princeton, NJ) intramuscularly at 24 and 48 h p.i.,
0.63 mg/3 ml levalbuterol HCl (Xopenex; Sepracor, Marl-
borough, MA) aerosol delivered by ultrasonic nebulization
over 2 min, or 0.5 mg/kg zanamivir (Relenza, Glaxo-Well-
come) delivered intranasally at 24 and 48 h p.i.
Histopathology
Lungs were fixed in 10% formalin and hematoxylin/
eosin (H/E)-stained sections prepared by Histoserv (Rock-
ville, MD). Epithelial cell destruction of small airways, large
airways, peribronchiolitis, interstitial pneumonitis, and
alveolitis were scored blind on a scale of 0 (normal) to 4
(severe inflammation or tissue destruction).
Statistical methods
A Student’s t test was used to determine significant differ-
ences between arithmetic means obtained from each group.Acknowledgments
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